Government Dental College and Research Institute, Bangalore
38
0
0
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 38 trials
100.0%
+13.5% vs industry average
3%
1 trials in Phase 3/4
0%
0 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (38)
Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.
Role: lead
Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate on Dentinal Hypersensitivity
Role: lead
Comparison of Efficacy of 5% Fluorocalcium Phosphosilicate Dentifrice and Potassium Nitrate Dentifrice on Dentinal Hypersensitivity
Role: lead
PRF+1% MF for Class II Mandibular Furcation Defects
Role: lead
Locally Delivered Metformin and Aloe Vera for Treatment of Intrabody Defects in Chronic Periodontitis
Role: lead
Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis
Role: lead
Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis
Role: lead
1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis
Role: lead
1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus
Role: lead
Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis
Role: lead
Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis
Role: lead
Anti-calculus Efficacy of a Dentrifice Containing Sodium Pyrophosphate and Potassium Pyrophosphate in Heavy Calculus Formers
Role: lead
Boric Acid in Degree 2 Furcation Defect
Role: lead
Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment
Role: lead
Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects
Role: lead
Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects
Role: lead
Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis
Role: lead
1% Metformin Gel in the Treatment of Class II Furcation Defects
Role: lead
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
Role: lead
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
Role: lead